Harbin Pharmaceutical Group Co., Ltd. is a limited liability company (Sino-foreign joint venture) registered in Harbin City, Heilongjiang Province on May 13, 1989. Its registered address is No. 68, Limin West Fourth Street, Limin Development Zone, Harbin City .
The unified social credit code/registration number of Harbin Pharmaceutical Group Co., Ltd. is 91230100127040288Q. The corporate legal person Xu Zhiyue is currently in business.
The business scope of Harbin Pharmaceutical Group Co., Ltd. is: (1) Invest in areas where the state allows foreign investment in accordance with the law; (2) According to the unanimous resolution of the board of directors of the enterprise invested by the joint venture company and its written authorization: 1 , assist or act as an agent for the enterprises in which it invests to purchase the machinery and equipment, office equipment and raw materials, components and spare parts required for the enterprise's own use at home and abroad, and sell the products produced by the enterprises in which it invests at home and abroad, and provide after-sales service Services; 2. With the consent and supervision of the foreign exchange management department, balance foreign exchange among the enterprises it invests in; 3. Provide technical support, employee training, and internal Personnel management and other services; 4. Assist the companies it invests in seeking loans and providing guarantees; (3) Establish a research and development center or department to engage in research, development and training activities related to the products and technologies of the companies it invests in, and transfer their research development results and provide corresponding technical services; (4) Provide consulting services to its shareholders and provide investment-related market information, investment policies and other consulting services to its affiliated companies; (5) Provide consulting services to shareholders and their affiliated companies ; (6) Undertake the service outsourcing business of its shareholders and affiliated companies; (7) With the approval of the China Banking Regulatory Commission, provide financial support to the enterprises it invests and establishes. (The company was changed from a domestic enterprise to a Sino-foreign joint venture on August 1, 2005). In Heilongjiang Province, the total registered capital of companies with similar business scope is 3.75 billion yuan, and the main capital is concentrated in ***2 companies with a scale of more than 50 million yuan. Within this province, the current registered capital of enterprises is excellent.
Harbin Pharmaceutical Group Co., Ltd. has invested in 14 companies and has 1 branch.
View more information and information about Harbin Pharmaceutical Group Co., Ltd. through Baidu Enterprise Credit.